Hosted on MSN1y
NRx Pharmaceuticals Nears Completion of Pivotal Trial for Bipolar Depression Treatment
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced that the last patient in its Phase 2b/3 study of NRX-101 recently completed their day 42 visit. The company is now preparing ...
MyChesCo on MSN5mon
NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has achieved a significant milestone in the development of its ...